Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 71-80 of 134

Page
per page
  1. Dimethylfraxetin
    N2285 Dimethylfraxetin
      ≥73.1 mg/mL
  2. Wedelolactone
    N2131 Wedelolactone
    Summary: IKK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥44.4 mg/mL
  3. Piceatannol
    N2031 Piceatannol
    Summary: p56lck/Syk inhibitor
      insoluble in H2O; ≥12.2 mg/mL
  4. U-73122
    B3422 U-73122
     1 Citation
    Target: PC-PLC
    Summary: inhibitor of phospholipase C, phospholipase A2, and 5-LO (5-lipoxygenase)
  5. Y-320
    B3425 Y-320
    Summary: immunomodulator
      ≥24.8 mg/mL
  6. Withaferin A
    B7199 Withaferin A
     1 Citation
    Summary: Prevents NF-κB activation by inhibiting activation of IKKβ
      Soluble in DMSO
  7. PR 39 (porcine)
    B5241 PR 39 (porcine)
    Summary: Antibacterial peptide
      Soluble to 1 mg/mL
  8. BAY-X 1005
    B5447 BAY-X 1005
    Summary: Potent FLAP inhibitor
      <36.14 mg/mL
  9. PF 184
    B5543 PF 184
    Summary: IKKβ inhibitor
      <61.91 mg/mL
  10. ACHP
    B5638 ACHP
    Summary: IκB kinase inhibitor
      <7.29 mg/mL

Items 71-80 of 134

Page
per page